At the contract signing ceremony held in Jongno-gu, Seoul, government officials such as Second Vice Minister of Health and Welfare Park Min-soo, MSD Vice President Sanat Chattopadhyay, Hilleman Research Center CEO Raman Rao, SK Discovery Vice Chairman Choi Chang-won, SK Bioscience President Ahn Jae-yong, Hoon Kim, CEO of Global R&BD, etc. attended. MSD is developing a next-generation Zaire Ebola vaccine candidate with improved process efficiency and stability of the currently approved and used Zaire Ebola vaccine Ervebo with the Hillemann Institute, an international non-profit research institute. In the future, if the candidate substance is successfully developed and approved by regulatory authorities, it is expected